BIOMAT Database Logo BIOMAT Database Logo

Longest Ongoing Support (13 Years) with Magnetically Levitated Left Ventricular Assist Device. 2020

Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
From the Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Germany.

Implantation of a left ventricular assist device (LVAD) is an established treatment in end-stage heart failure. The longevity of LVAD support systems remains uncertain to a great extent because patients usually undergo transplantation, are weaned or die while on support before the maximum service life of these pumps is reached. We report about the hitherto longest published and still ongoing LVAD support of a 65 year old patient who received an Incor LVAD (Berlin Heart, Berlin, Germany, produced 2002-2018) 13 years ago. After pump exchange due to driveline damage, the patients were discharged home.

UI MeSH Term Description Entries
D008297 Male Males
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006353 Heart-Assist Devices Small pumps, often implantable, designed for temporarily assisting the heart, usually the LEFT VENTRICLE, to pump blood. They consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors. Artificial Ventricle,Heart Assist Device,Heart Ventricle, Artificial,Pumps, Heart-Assist,Vascular-Assist Device,Vascular-Assist Devices,Ventricle-Assist Device,Ventricular Assist Device,Artificial Heart Ventricle,Artificial Heart Ventricles,Artificial Ventricles,Assist Device, Heart,Assist Device, Ventricular,Assist Devices, Heart,Assist Devices, Ventricular,Device, Heart Assist,Device, Heart-Assist,Device, Vascular-Assist,Device, Ventricle-Assist,Device, Ventricular Assist,Devices, Heart Assist,Devices, Heart-Assist,Devices, Vascular-Assist,Devices, Ventricle-Assist,Devices, Ventricular Assist,Heart Assist Devices,Heart Ventricles, Artificial,Heart-Assist Device,Heart-Assist Pump,Heart-Assist Pumps,Pump, Heart-Assist,Pumps, Heart Assist,Vascular Assist Device,Vascular Assist Devices,Ventricle Assist Device,Ventricle, Artificial,Ventricle, Artificial Heart,Ventricle-Assist Devices,Ventricles, Artificial,Ventricles, Artificial Heart,Ventricular Assist Devices
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013995 Time The dimension of the physical universe which, at a given place, orders the sequence of events. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Effects, Long-Term,Effects, Longterm,Long-Term Effects,Longterm Effects,Effect, Long-Term,Effect, Longterm,Effects, Long Term,Long Term Effects,Long-Term Effect,Longterm Effect
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
Magnetically Levitated Left Ventricular Assist Device.
August 2019, The New England journal of medicine,
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
Magnetically Levitated Left Ventricular Assist Device. Reply.
August 2019, The New England journal of medicine,
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
April 2019, The New England journal of medicine,
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
DuraHeart™ magnetically levitated left ventricular assist device: Osaka University experience.
January 2013, Circulation journal : official journal of the Japanese Circulation Society,
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
HeartQuest ventricular assist device magnetically levitated centrifugal blood pump.
May 2006, Artificial organs,
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
[Left ventricular assist system with a magnetically levitated impeller technology].
September 2002, Nihon Geka Gakkai zasshi,
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
Sound analysis of the magnetically levitated left ventricular assist device HeartMate 3™.
December 2019, The International journal of artificial organs,
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
Hemodynamic effects of a fully magnetically levitated centrifugal-flow left ventricular assist device.
January 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
Midterm Results of Minimally Invasive Left Thoracotomy Fully Magnetically Levitated Left Ventricular Assist Device Implantation.
September 2021, ASAIO journal (American Society for Artificial Internal Organs : 1992),
Evgenij V Potapov, and Friedrich Kaufmann, and Markus Müller, and Johanna Mulzer, and Volkmar Falk
Leadless pacemaker implantation in a patient with a fully magnetically levitated left ventricular assist device.
June 2021, Pacing and clinical electrophysiology : PACE,
Copied contents to your clipboard!